Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Coagulopathy of Immunodermatologic Diseases — Stella

Home/Autoimmune Bullous Dermatosis/Coagulopathy of Immunodermatologic Diseases

View on ClinicalTrials.gov

Recruiting

Back to Autoimmune Bullous Dermatosis trials

Coagulopathy of Immunodermatologic Diseases

Trial locations(1 site)

United States

University of Nebraska Medical Center, Omaha, Nebraska

Key details

Sponsor

University of Nebraska

Enrollment target

~39 participants

Started

May 2023

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

19 Years and older

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.